On Tuesday, co-founder and CEO of BioNTech, Ugur Sahin, told that BioNTech and Pfizer have assured that they can get the Coronavirus vaccine, which is regulatory for approval by the early November or mid of October.
In a lengthy interview with a media company, CNN, Sahin said that it has an outstanding profile, and he considers this COVID-19 vaccine, near perfect, and which held a near-perfect profile. Moreover, American drug giant Pfizer and a German company BioNTech described that they planned to serve a hundred million doses of vaccine, BNT162, till the end of the year and above 1.3 billion vaccine doses in 2021.
Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur Sahin told CNN Tuesday. https://t.co/So5tMAl9k5
— CNN Philippines (@cnnphilippines) September 8, 2020
American Department of HHS (Health and Human Services) and the Defense Department declared a 1.95 billion USD agreement with American drug giant Pfizer to give a hundred million vaccine doses of Coronavirus. The agreement even permits the American government to get an additional 500 million vaccine doses.
Ugur Sahin described to CNN that he thinks that approval for emergency use will be allowed abruptly by regulatory authorities, including that the firm’s understanding of the model of action in mixture with the safety data coming from the running trial, which means that they attained a lot of confidence in the vaccine.
He said that yes, we believe that we acquired a safe and secure product, and we believe that we will show progress. Furthermore, Sahin described that antibody reaction in both the elders and young adults have verified to be strong thus far, with minimum side-effects.
vaccine has much lower symptoms like headache
Sahin continued that they don’t observe frequent fever, and only a small amount of the participants in this trial got a fever. They even observe very small symptoms, such as feeling tired or headache. Besides this, the symptoms seen with this vaccine are not permanent, they are generally observed for one or two days; after this, they are gone.
While Pfizer and BioNTech said that the approval would occur by the middle of October, but federal officials have described to CNN that they believe this is an optimistic timeline.
An official body who is close to Operation Wrap Speed previously told a media firm known as CNN that he doesn’t know any scientist involved in this struggle who believes we will be getting shots into arms at any time before Election Day.